Global CAR-T Cell Immunotherapies for Cancer Market Growth (Status and Outlook) 2022-2028
- LP 4912462
- 89 Pages
- March 2022
- Medical Devices
The United States CAR-T Cell Immunotherapies for Cancer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CAR-T Cell Immunotherapies for Cancer market, reaching US$ million by the year 2028. As for the Europe CAR-T Cell Immunotherapies for Cancer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CAR-T Cell Immunotherapies for Cancer players cover NOVARTIS, Penn, Fosun Pharma, and Celgene Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Immunotherapies for Cancer market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CD19
BCMA
EPCAM
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hematological Cancer
Solid Tumor
Other Oncological Disorders
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
NOVARTIS
Penn
Fosun Pharma
Celgene Corporation
Legend Biotech
SHEBA
JW Therapeutics
Protheragen
EXUMA Biotechnology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR-T Cell Immunotherapies for Cancer Market Size 2017-2028
2.1.2 CAR-T Cell Immunotherapies for Cancer Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR-T Cell Immunotherapies for Cancer Segment by Type
2.2.1 CD19
2.2.2 BCMA
2.2.3 EPCAM
2.3 CAR-T Cell Immunotherapies for Cancer Market Size by Type
2.3.1 CAR-T Cell Immunotherapies for Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type (2017-2022)
2.4 CAR-T Cell Immunotherapies for Cancer Segment by Application
2.4.1 Hematological Cancer
2.4.2 Solid Tumor
2.4.3 Other Oncological Disorders
2.5 CAR-T Cell Immunotherapies for Cancer Market Size by Application
2.5.1 CAR-T Cell Immunotherapies for Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application (2017-2022)
3 CAR-T Cell Immunotherapies for Cancer Market Size by Player
3.1 CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Players
3.1.1 Global CAR-T Cell Immunotherapies for Cancer Revenue by Players (2020-2022)
3.1.2 Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Players (2020-2022)
3.2 Global CAR-T Cell Immunotherapies for Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T Cell Immunotherapies for Cancer by Regions
4.1 CAR-T Cell Immunotherapies for Cancer Market Size by Regions (2017-2022)
4.2 Americas CAR-T Cell Immunotherapies for Cancer Market Size Growth (2017-2022)
4.3 APAC CAR-T Cell Immunotherapies for Cancer Market Size Growth (2017-2022)
4.4 Europe CAR-T Cell Immunotherapies for Cancer Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Growth (2017-2022)
5 Americas
5.1 Americas CAR-T Cell Immunotherapies for Cancer Market Size by Country (2017-2022)
5.2 Americas CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022)
5.3 Americas CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cell Immunotherapies for Cancer Market Size by Region (2017-2022)
6.2 APAC CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022)
6.3 APAC CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CAR-T Cell Immunotherapies for Cancer by Country (2017-2022)
7.2 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022)
7.3 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CAR-T Cell Immunotherapies for Cancer by Region (2017-2022)
8.2 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CAR-T Cell Immunotherapies for Cancer Market Forecast
10.1 Global CAR-T Cell Immunotherapies for Cancer Forecast by Regions (2023-2028)
10.1.1 Global CAR-T Cell Immunotherapies for Cancer Forecast by Regions (2023-2028)
10.1.2 Americas CAR-T Cell Immunotherapies for Cancer Forecast
10.1.3 APAC CAR-T Cell Immunotherapies for Cancer Forecast
10.1.4 Europe CAR-T Cell Immunotherapies for Cancer Forecast
10.1.5 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Forecast
10.2 Americas CAR-T Cell Immunotherapies for Cancer Forecast by Country (2023-2028)
10.2.1 United States CAR-T Cell Immunotherapies for Cancer Market Forecast
10.2.2 Canada CAR-T Cell Immunotherapies for Cancer Market Forecast
10.2.3 Mexico CAR-T Cell Immunotherapies for Cancer Market Forecast
10.2.4 Brazil CAR-T Cell Immunotherapies for Cancer Market Forecast
10.3 APAC CAR-T Cell Immunotherapies for Cancer Forecast by Region (2023-2028)
10.3.1 China CAR-T Cell Immunotherapies for Cancer Market Forecast
10.3.2 Japan CAR-T Cell Immunotherapies for Cancer Market Forecast
10.3.3 Korea CAR-T Cell Immunotherapies for Cancer Market Forecast
10.3.4 Southeast Asia CAR-T Cell Immunotherapies for Cancer Market Forecast
10.3.5 India CAR-T Cell Immunotherapies for Cancer Market Forecast
10.3.6 Australia CAR-T Cell Immunotherapies for Cancer Market Forecast
10.4 Europe CAR-T Cell Immunotherapies for Cancer Forecast by Country (2023-2028)
10.4.1 Germany CAR-T Cell Immunotherapies for Cancer Market Forecast
10.4.2 France CAR-T Cell Immunotherapies for Cancer Market Forecast
10.4.3 UK CAR-T Cell Immunotherapies for Cancer Market Forecast
10.4.4 Italy CAR-T Cell Immunotherapies for Cancer Market Forecast
10.4.5 Russia CAR-T Cell Immunotherapies for Cancer Market Forecast
10.5 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Forecast by Region (2023-2028)
10.5.1 Egypt CAR-T Cell Immunotherapies for Cancer Market Forecast
10.5.2 South Africa CAR-T Cell Immunotherapies for Cancer Market Forecast
10.5.3 Israel CAR-T Cell Immunotherapies for Cancer Market Forecast
10.5.4 Turkey CAR-T Cell Immunotherapies for Cancer Market Forecast
10.5.5 GCC Countries CAR-T Cell Immunotherapies for Cancer Market Forecast
10.6 Global CAR-T Cell Immunotherapies for Cancer Forecast by Type (2023-2028)
10.7 Global CAR-T Cell Immunotherapies for Cancer Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 NOVARTIS
11.1.1 NOVARTIS Company Information
11.1.2 NOVARTIS CAR-T Cell Immunotherapies for Cancer Product Offered
11.1.3 NOVARTIS CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 NOVARTIS Main Business Overview
11.1.5 NOVARTIS Latest Developments
11.2 Penn
11.2.1 Penn Company Information
11.2.2 Penn CAR-T Cell Immunotherapies for Cancer Product Offered
11.2.3 Penn CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Penn Main Business Overview
11.2.5 Penn Latest Developments
11.3 Fosun Pharma
11.3.1 Fosun Pharma Company Information
11.3.2 Fosun Pharma CAR-T Cell Immunotherapies for Cancer Product Offered
11.3.3 Fosun Pharma CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Fosun Pharma Main Business Overview
11.3.5 Fosun Pharma Latest Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Information
11.4.2 Celgene Corporation CAR-T Cell Immunotherapies for Cancer Product Offered
11.4.3 Celgene Corporation CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Celgene Corporation Main Business Overview
11.4.5 Celgene Corporation Latest Developments
11.5 Legend Biotech
11.5.1 Legend Biotech Company Information
11.5.2 Legend Biotech CAR-T Cell Immunotherapies for Cancer Product Offered
11.5.3 Legend Biotech CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Legend Biotech Main Business Overview
11.5.5 Legend Biotech Latest Developments
11.6 SHEBA
11.6.1 SHEBA Company Information
11.6.2 SHEBA CAR-T Cell Immunotherapies for Cancer Product Offered
11.6.3 SHEBA CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 SHEBA Main Business Overview
11.6.5 SHEBA Latest Developments
11.7 JW Therapeutics
11.7.1 JW Therapeutics Company Information
11.7.2 JW Therapeutics CAR-T Cell Immunotherapies for Cancer Product Offered
11.7.3 JW Therapeutics CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 JW Therapeutics Main Business Overview
11.7.5 JW Therapeutics Latest Developments
11.8 Protheragen
11.8.1 Protheragen Company Information
11.8.2 Protheragen CAR-T Cell Immunotherapies for Cancer Product Offered
11.8.3 Protheragen CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Protheragen Main Business Overview
11.8.5 Protheragen Latest Developments
11.9 EXUMA Biotechnology
11.9.1 EXUMA Biotechnology Company Information
11.9.2 EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Product Offered
11.9.3 EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 EXUMA Biotechnology Main Business Overview
11.9.5 EXUMA Biotechnology Latest Developments
12 Research Findings and Conclusion
Table 1. CAR-T Cell Immunotherapies for Cancer Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CD19
Table 3. Major Players of BCMA
Table 4. Major Players of EPCAM
Table 5. CAR-T Cell Immunotherapies for Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type (2017-2022)
Table 8. CAR-T Cell Immunotherapies for Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application (2017-2022)
Table 11. Global CAR-T Cell Immunotherapies for Cancer Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Player (2020-2022)
Table 13. CAR-T Cell Immunotherapies for Cancer Key Players Head office and Products Offered
Table 14. CAR-T Cell Immunotherapies for Cancer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CAR-T Cell Immunotherapies for Cancer Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Regions (2017-2022)
Table 19. Americas CAR-T Cell Immunotherapies for Cancer Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Country (2017-2022)
Table 21. Americas CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type (2017-2022)
Table 23. Americas CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application (2017-2022)
Table 25. APAC CAR-T Cell Immunotherapies for Cancer Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Region (2017-2022)
Table 27. APAC CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type (2017-2022)
Table 29. APAC CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application (2017-2022)
Table 31. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Country (2017-2022)
Table 33. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type (2017-2022)
Table 35. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of CAR-T Cell Immunotherapies for Cancer
Table 44. Key Market Challenges & Risks of CAR-T Cell Immunotherapies for Cancer
Table 45. Key Industry Trends of CAR-T Cell Immunotherapies for Cancer
Table 46. Global CAR-T Cell Immunotherapies for Cancer Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global CAR-T Cell Immunotherapies for Cancer Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global CAR-T Cell Immunotherapies for Cancer Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share Forecast by Application (2023-2028)
Table 52. NOVARTIS Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 53. NOVARTIS CAR-T Cell Immunotherapies for Cancer Product Offered
Table 54. NOVARTIS CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. NOVARTIS Main Business
Table 56. NOVARTIS Latest Developments
Table 57. Penn Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 58. Penn CAR-T Cell Immunotherapies for Cancer Product Offered
Table 59. Penn Main Business
Table 60. Penn CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Penn Latest Developments
Table 62. Fosun Pharma Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 63. Fosun Pharma CAR-T Cell Immunotherapies for Cancer Product Offered
Table 64. Fosun Pharma Main Business
Table 65. Fosun Pharma CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Fosun Pharma Latest Developments
Table 67. Celgene Corporation Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 68. Celgene Corporation CAR-T Cell Immunotherapies for Cancer Product Offered
Table 69. Celgene Corporation Main Business
Table 70. Celgene Corporation CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Celgene Corporation Latest Developments
Table 72. Legend Biotech Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 73. Legend Biotech CAR-T Cell Immunotherapies for Cancer Product Offered
Table 74. Legend Biotech Main Business
Table 75. Legend Biotech CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Legend Biotech Latest Developments
Table 77. SHEBA Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 78. SHEBA CAR-T Cell Immunotherapies for Cancer Product Offered
Table 79. SHEBA Main Business
Table 80. SHEBA CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. SHEBA Latest Developments
Table 82. JW Therapeutics Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 83. JW Therapeutics CAR-T Cell Immunotherapies for Cancer Product Offered
Table 84. JW Therapeutics Main Business
Table 85. JW Therapeutics CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. JW Therapeutics Latest Developments
Table 87. Protheragen Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 88. Protheragen CAR-T Cell Immunotherapies for Cancer Product Offered
Table 89. Protheragen Main Business
Table 90. Protheragen CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Protheragen Latest Developments
Table 92. EXUMA Biotechnology Details, Company Type, CAR-T Cell Immunotherapies for Cancer Area Served and Its Competitors
Table 93. EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Product Offered
Table 94. EXUMA Biotechnology Main Business
Table 95. EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. EXUMA Biotechnology Latest Developments
List of Figures
Figure 1. CAR-T Cell Immunotherapies for Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type in 2021
Figure 7. CAR-T Cell Immunotherapies for Cancer in Hematological Cancer
Figure 8. Global CAR-T Cell Immunotherapies for Cancer Market: Hematological Cancer (2017-2022) & ($ Millions)
Figure 9. CAR-T Cell Immunotherapies for Cancer in Solid Tumor
Figure 10. Global CAR-T Cell Immunotherapies for Cancer Market: Solid Tumor (2017-2022) & ($ Millions)
Figure 11. CAR-T Cell Immunotherapies for Cancer in Other Oncological Disorders
Figure 12. Global CAR-T Cell Immunotherapies for Cancer Market: Other Oncological Disorders (2017-2022) & ($ Millions)
Figure 13. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application in 2021
Figure 14. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Player in 2021
Figure 15. Global CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Regions (2017-2022)
Figure 16. Americas CAR-T Cell Immunotherapies for Cancer Market Size 2017-2022 ($ Millions)
Figure 17. APAC CAR-T Cell Immunotherapies for Cancer Market Size 2017-2022 ($ Millions)
Figure 18. Europe CAR-T Cell Immunotherapies for Cancer Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size 2017-2022 ($ Millions)
Figure 20. Americas CAR-T Cell Immunotherapies for Cancer Value Market Share by Country in 2021
Figure 21. Americas CAR-T Cell Immunotherapies for Cancer Consumption Market Share by Type in 2021
Figure 22. Americas CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application in 2021
Figure 23. United States CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Region in 2021
Figure 28. APAC CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application in 2021
Figure 29. China CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 33. India CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Country in 2021
Figure 36. Europe CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type in 2021
Figure 37. Europe CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application in 2021
Figure 38. Germany CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 39. France CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Market Share by Application in 2021
Figure 46. Egypt CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country CAR-T Cell Immunotherapies for Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 52. APAC CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 53. Europe CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 55. United States CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 56. Canada CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 57. Mexico CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 58. Brazil CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 59. China CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 60. Japan CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 61. Korea CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 63. India CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 64. Australia CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 65. Germany CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 66. France CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 67. UK CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 68. Italy CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 69. Russia CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 70. Spain CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 71. Egypt CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 72. South Africa CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 73. Israel CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 74. Turkey CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries CAR-T Cell Immunotherapies for Cancer Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
